Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$32.77 - $39.4 $1,966 - $2,364
-60 Reduced 4.41%
1,300 $46,000
Q3 2022

Nov 01, 2022

SELL
$39.88 - $44.65 $159 - $178
-4 Reduced 0.29%
1,360 $54,000
Q2 2022

Aug 10, 2022

BUY
$37.53 - $44.22 $2,401 - $2,830
64 Added 4.92%
1,364 $58,000
Q4 2020

Feb 12, 2021

BUY
$36.12 - $50.05 $46,956 - $65,064
1,300 New
1,300 $65,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Lee Financial CO Portfolio

Follow Lee Financial CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

News

Stay updated on Lee Financial CO with notifications on news.